Related Experiment Video
Updated: Jun 4, 2026
08:19
Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
Published on: February 22, 2018
Cardiac gene expression profiling - the quest for an atrium-specific biomarker
A H Maass1, A-M R De Jong, M D Smit
1Departments of Cardiology and Experimental Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Summary
Researchers identified novel atrium-enriched genes using bioinformatics to potentially serve as biomarkers for atrial fibrillation risk stratification. This study highlights potential new diagnostic tools for heart disease.
Area of Science:
- Cardiovascular Biology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- Tissue-specific biomarkers are crucial for organ-specific disease diagnostics and risk stratification.
- Currently, no atrium-specific biomarkers exist for stratifying atrial disease risk, such as atrial fibrillation.
- Bioinformatic approaches, including mRNA microarrays, can identify tissue-enriched genes for biomarker development.
Purpose of the Study:
- To identify genes preferentially expressed in atrial cardiomyocytes compared to ventricular cardiomyocytes.
- To discover potential novel biomarkers for atrial disease and risk stratification.
- To investigate gene expression patterns related to atrial and ventricular cell function.
Main Methods:
- Utilized RNA microarray analysis to compare gene expression between atrial and ventricular cardiomyocytes.
- Employed quantitative real-time polymerase chain reaction (qRT-PCR) for confirmation of identified gene expression levels.
- Analyzed gene expression differences to identify atrium-enriched and ventricle-enriched genes.
Main Results:
- Several atrium-enriched genes (e.g., serpine1, ltbp2) and ventricle-enriched genes (e.g., alpha-adrenergic receptor subtype 1b, S100A1) were identified.
- Atrial natriuretic peptide (ANP) mRNA showed higher expression in atrial cardiomyocytes, with altered expression upon adrenergic stimulation.
- Brain-type natriuretic peptide (BNP) expression did not differ between atrial and ventricular cells, offering a potential explanation for NT-proBNP levels in atrial fibrillation.
Conclusions:
- The identified atrium-enriched genes warrant further investigation in human tissues as potential biomarkers for atrial stress.
- The findings provide a basis for developing novel diagnostic and risk stratification tools for atrial fibrillation.
- Understanding differential gene expression in cardiomyocytes is key to advancing cardiovascular diagnostics.
